Global increases in seizure susceptibility in mice lacking 5-HT(2C) receptors: A behavioral analysis

Experimental Neurology

Volumn 154, Issue 2, 1998, Pages 522-530

  Applegate, Craig D ^a   Tecott, Laurence H ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 HT(2C) receptor; Electroconvulsive shock; Flurothyl; Genetics; Kindling; Seizures; Serotonin; Transgenic mice

Indexed keywords

FLUROTHYL; MESULERGINE; SEROTONIN 2C RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; ELECTRIC SHOCK; EPILEPSY; FEMALE; GENE DISRUPTION; GENE TARGETING; GRAND MAL SEIZURE; KINDLING; MALE; MOUSE MUTANT; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; TONIC SEIZURE;

EID: 0032444370     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6901     Document Type: Article

References (46)

1. Applegate C. D., Burchfiel J. L., Ferland R. J., Nierenberg J. Rhinencephalic networks in the late stages of kindling. Kindling 5. 1998;Plenum Press, New York. p. 151-165.
2. Applegate C. D., Ferland R. J. The ventromedial nucleus of the hypothalamus and seizure propagation in C57BL/6J mice. Soc. Neurosci. Abs. 23:1997;811.
3. Applegate C. D., Samoriski G. M., Burchfiel J. L. Evidence for the interaction of brainstem systems mediating seizure expression in kindling and electroconvulsive shock seizure models. Epilepsy Res. 10:1991;142-147.
4. Applegate C. D., Burchfiel J. L., Neumann P. E. Genetic contributions to kindling: An experimental approach. Wada J. A. Kindling 4. 1990;113-126 Plennum Press, New York.
5. Applegate C. D., Burchfiel J. L., Neumann P. E. A classical genetic and recombinant inbred strain analysis of seizure susceptibility of mice to pentylenetetrazol. Epilepsia. 29:1988;676.
6. Applegate C. D., Samoriski G. M., Neumann P. E. Susceptibility to electroconvulsive shock in DBA/2J and C57BL/6J mice: A classical genetic and recombinant inbred strain analysis. Epilepsia. 30:1989;699.
7. Bard J. A., Zgombick J. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 268:1993;23422-23426.
8. 2C. Nature (Genetics). 16:1997;387-390.
9. Browning R. A., Nelson D. K. Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transsections. Exp. Neurol. 93:1986;546-556.
10. Browning R. A. Anatomy of generalized convulsive seizures. Malofosse. Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. 1994;399-413 Libbey, London.
11. Browning R. A., Wang C., Lanker M. L., Jobe P. C. Electroshock and pentylenetetrazol-induced seizures in genetically epilepsy-prone rats: Differences in threshold and pattern. Epilepsy Res. 6:1990;1-11.
12. Closse A. [3H]Mesulergine, a selective ligand for serotonin-2 receptors. Life Sci. 32:1983;2485-2495.
13. Coffey L. L., Reith M. E., Chen N. H., Mishra P. K., Jobe P. C. Amygdala kindling of forebrain seizures and the occurrence of brainstem seizures in genetically epilepsy-prone rats. Epilepsia. 37:1996;188-197.
14. Daily J. W., Yan Q. S., Adams-Curtis L. E., Ryu J. R., Ko K. H., Mishra P. K., Jobe P. C. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat. Life Sciences. 58:1995;259-266.
15. Erlander M., Lovenberg T. Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc. Natl. Acad. Sci. USA. 90:1993;3452-3456.
16. Faingold C. L. Neuronal networks in the genetically epilepsy-prone rat. Escueta D. Basic Mechanisms of the Epilepsies. 1998;Lippincott, New York.
17. Favale E., Rubino V., Mainardi P., Lunardi G., Albano C. Anticonvulsant effects of fluoxetine in humans. Neurology. 45:1995;1926-1927.
18. Ferland R. J., Applegate C. D. Decreased brainstem seizure thresholds and facilitated seizure propagation in mice exposed to repeated flurothyl-induced forebrain seizures. Epilepsy Res. 30:1998;49-62.
19. Kelly M. E., McIntyre D. C. Perirhinal cortical involvement in limbic kindled seizures. Epilepsy Res. 26:1996;233-243.
20. Lappalainen J., Zhang L., Dean M., Oz M., Ozaki N., Yu D. H., Virkkunen M., Weight F., Linnoila M., Goldman D. Identification, expression and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2C receptor gene (HTR2C). Genomics. 27:1995;274-279.
21. Leysen J. E., Gommeren W. Receptor-binding propertiesin vitroin vivo. Mol. Pharmacol. 27:1985;600-611.
22. Monsma F. J., Shen Y. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43:1993;320-327.
23. Okada M., Hirano T. Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus. Epilepsy Res. 28:1997;143-153.
24. Pacia S. V., Devinsky O. Clozapine-related seizures: experience with 5,629 patients. Neurology. 44:1994;2247-2249.
25. Pasini A., Tortorella A., Gale K. The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res. 724:1996;84-88.
26. 2. Mol. Brain Res. 23:1994;163-178.
27. Post R. M., Weiss S. R. B. The neurobiology of treatment-resistant mood disorders. Bloom F. E., Kupfer D. J. Psychopharmacology: The Fourth Generation of Progress. 1995;1155-1170 Raven Press, NY.
28. Purdy R. E., Julien R. M. Effects of carbamazepine on thein vitro. Epilepsia. 18:1977;251-257.
29. Przegalinski E., Baran L., Siwanowicz J. Role of 5-hydroxytryptamine receptor subtypes in the 1-[3-(tritrifluomethyl)phenyl] piperazine-induced increase in threshold for maximal electroconvulsions in mice. Epilepsia. 35:1994;889-894.
30. Racine R. J., Coscina D. V. Effects of midbrain raphe lesions or systemic PCPA on the development of kindled seizures in the rat. Brain Res. Bull. 4:1979;1-7.
31. Racine R. J. Modification of seizure activity by electrical stimulation. II. Motor seizure. EEG Clin. Neurophysiol. 32:1972;281-294.
32. Reigel C. E., Jobe P. C., Dailey J. W., Savage D. D. Ontogeny of sound-induced seizures in the genetically epilepsy-prone rat. Epilepsy Res. 4:1989;63-71.
33. Samoriski G. M., Applegate C. D. Repeated generalized seizures induce time-dependent changes in the behavioral seizure response independent of continued seizure induction. J. Neurosci. 17:1997;5581-5590.
34. Samoriski G. M., Piekut D. T., Applegate C. D. Regional analysis of the spatial pattern of Fos induction in brain following flurothyl kindling. Neuroscience. 84:1998;1209-1222.
35. Slatnick M. A., Maring-Smith M. L., Clough R. W., Wang C., Dailey J. W., Jobe P. C., Browning R. A. Effect of 5,7-dihydroxytryptamine on audiogenic seizures in GEPR rats. Life Sci. 59:1996;1763-1771.
36. Slatnick M. A., Dailey J. W., Jobe P. C., Browning R. A. Abnormalities in brain serotonin concentration, high-affinity uptake and tryptophan hydroxylase activity in severe-seizure GEPR rats. Epilepsia. 37:1996;311-321.
37. Schirrmacher K., Mayer A. Effect of carbamazepine on action potentials and calcium currents in rat spinal ganglion cells in vitro. Neuropsychobiology. 27:1993;176-179.
38. 2C. Nature. 374:1995;542-546.
39. Teitler M., Herrick-Davis K. Multiple serotonin receptor sub-types: Molecular cloning and functional expression. Crit. Rev. Neurobiol. 8:1994;175-188.
40. Umbricht D., Kane J. M. Medical complications of new antipsychotic drugs. Schizophrenia Bull. 22:1996;475-483.
41. Wada J. A., Balzamo B. S., Meldrum B. S., Naquet R. Behavioural and electrographic effects of 5-hydroxytryptophan and D,L-parachlorophenylalanine on epileptic Senegalese baboon. EEG Clin. Neurophysiol. 33:1972;520-526.
42. Wada Y., Shiraishi J., Nakamura M., Hasegawa H. Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychopharmacology. 118:1995;305-309.
43. Welch J., Manschreck T., Redmond D. Clozapine-induced seizures and EEG changes. J. Neuropsychiatry Clin. Neurosci. 6:1994;250-256.
44. Willow M., Catterall W. A. Inhibition of binding of [3H]batrachotoxin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol. Pharmacol. 22:1982;627-635.
45. Wright D. E., Seroogy K. B., Lundgren K. H., Davis B. M., Jennes L. Comparative localization of the serotonin 1A, 1C and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351:1995;357-373.
46. Zifa E., Fillion G. 5-hydroxytryptamine receptors. Pharmacol. Rev. 44:1992;401-458.